NCT05273034

Brief Summary

Reducing the mortality and morbidity of sepsis is a worldwide priority for almost 20 years. Since an observational study in the NY state, which reported in-hospital mortality increased, associated with each supplemental hour to complete the sepsis bundle, SSC guidelines have decided in 2018 to recommend a short timeframe of 1-h to complete the sepsis bundle. This new recommendation is vividly debated due to a lack of evidences of its relevance. No trial has ever studied a sepsis intervention when applied as early as Emergency Department ED triage (newly recommended 1-h sepsis bundle consider time zero as time of ED triage). The aim of this trial is to demonstrate that the early implementation at ED triage of the 1-hour bundle by ED physicians improves in-hospital mortality in patients with sepsis, and therefore provides the required robust evidence for the SSC guidance to enhance physicians and stakeholder adherence. This is a superiority, international multicenter, open trial with a stepped wedge randomisation. All centers will recruit adult emergency patients with suspicion of sepsis as defined by a suspicion of infection and suspicion of life threatening organ dysfunction (quick SOFA or SOFA ≥ 2, hypotension or hyperlactatemia). According to the center period, the management of sepsis patients will be based either following the current recommended 1-hour sepsis bundle (intervention group) or at the discretion of the treating ED physician as in current routine practice (control group). There is no intervention that is "added" by the research.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
873

participants targeted

Target at P75+ for not_applicable sepsis

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2022

Completed
29 days until next milestone

First Posted

Study publicly available on registry

March 10, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

June 13, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 13, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 13, 2023

Completed
Last Updated

February 26, 2024

Status Verified

February 1, 2024

Enrollment Period

1.3 years

First QC Date

February 9, 2022

Last Update Submit

February 23, 2024

Conditions

Keywords

Sepsis1-hour sepsis bundleEmergency department

Outcome Measures

Primary Outcomes (1)

  • In-hospital mortality

    Safety Issue ? : Yes / No

    truncated at day 28

Secondary Outcomes (7)

  • Amount of fluid resuscitation

    in the first 24 hours

  • Acute heart failure

    During the first 24 hours

  • SOFA score

    Up to 3 days

  • ICU length of stay

    Up to 3 days

  • Total number of days under mechanical ventilation, renal replacement therapy, and vasopressor-free

    within 28 days

  • +2 more secondary outcomes

Study Arms (2)

1-h sepsis bundle

EXPERIMENTAL
Procedure: 1-hour sepsis bundle

Current practice

NO INTERVENTION

Interventions

The sepsis management will be delivered in a timely manner within 60 minutes of ED triage including * usual test and treatment * blood culture * lactate measurement * broad spectrum antibiotics * In case of hypotension or lactate \> 4, rapid administration of 30ml/kg crystalloid fluid resuscitation will be mandated * In case of initial elevated lactate (\> 2 mmol/l), a second lactate measurement should be done after initial fluid resuscitation.

1-h sepsis bundle

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ED adult patients, with suspected infection
  • AND at least one of the following:
  • Serum lactate \> 2.0 mmol/l
  • Systolic blood pressure \< 90 mmHg
  • Suspicion of sepsis as defined by the SEPSIS-3 International consensus: life threatening organ dysfunction identified by a SOFA score of 2 at least or a quick SOFA score of 2 at least (altered consciousness, systolic blood pressure \< 100 mmHg, respiratory rate \> 22)

You may not qualify if:

  • Patient living in assisted-living home or nursing home or palliative center
  • Patient under legal protection measure (tutorship or curatorship) and patient deprived of freedom
  • Anticipated life expectancy \< 3 months or "do not resuscitate" order
  • Known acute heart failure
  • No social security
  • Pregnancy and breastfeeding
  • Prisoners
  • Participation in another interventional trial (RIPH 1 et 2)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emergency department Hospital Pitié-Salpêtrière

Paris, 75013, France

Location

MeSH Terms

Conditions

SepsisEmergencies

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Study Officials

  • Yonathan FREUND, PU-PH

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2022

First Posted

March 10, 2022

Study Start

June 13, 2022

Primary Completion

October 13, 2023

Study Completion

October 13, 2023

Last Updated

February 26, 2024

Record last verified: 2024-02

Locations